查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2003551

全球痤疮皮肤贴片市场：按产品类型、贴片技术、成分类型、年龄层、最终用户、分销管道和地区划分－市场规模、行业动态、机会分析和预测（2026-2035 年）

Global Anti-Acne Dermal Patch Market: By Product Type, Patch Technology, Ingredient Type, Age Group, End Users, Distribution Channel, Region-Market Size, Industry Dynamics, Opportunity Analysis and Forecast For 2026-2035
出版日期: | 出版商: Astute Analytica | 英文 328 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球痤疮贴片市场正经历快速扩张，反映出强劲的消费者需求和不断变化的护肤趋势。预计到2025年，该市场规模约为6.9321亿美元，未来十年将成长近一倍，到2035年达到12.7711亿美元。这一成长意味着在2026年至2035年的预测期内，复合年增长率将达到4.6%。推动这一强劲市场趋势的因素有很多，包括全球痤疮患病率的上升、消费者对非侵入性治疗方法的偏好日益增强，以及电子商务平台的爆炸式增长，使得更多消费者能够更容易地购买这些产品。

推动这一成长的主要因素之一是先进贴片技术的日益普及，尤其是亲水胶体和微针贴片。亲水胶体贴片因其价格实惠且在治疗痤疮方面疗效显着而备受青睐。另一方面，微针贴片则吸引了那些寻求能够更有效率地输送活性成分的创新解决方案的消费者。这些技术的结合为消费者提供了丰富的选择，以满足不同类型痤疮和治疗需求，从而进一步促进了市场扩张。

显着的市场趋势

欧美市场领导企业透过采用名为「SKU扩张」的策略，成功确立了其在零售分销领域的统治地位。这种策略在单一品牌下提供种类繁多的产品，涵盖痤疮的各个阶段，有效阻止竞争对手抢占货架空间。透过提供「Mighty Patch Original」、「Invisible」、「Surface」、「Micropoint」和「Face」等产品，这些公司确保消费者能够找到适合自身需求的解决方案，无论是早期痘痘还是严重痤疮。

在韩国美妆领域，COSRX在「网红」品牌和亚马逊等电商平台上拥有强大的影响力。 COSRX专注于「价值密度」概念，致力于以亲民的价格提供高浓度活性成分的高品质高效产品，从而建立起忠实的粉丝群。这种价值提案与那些寻求可靠护肤方案而非高价产品的消费者产生了强烈的共鸣。 COSRX凭藉其创新和高效的口碑，在电商平台上的策略布局进一步巩固了其声誉。在这些平台上，客户评价和品牌知名度在推动销售方面发挥着至关重要的作用。

另一方面，作为该领域的资深企业，3M的独特之处在于它是亲水胶体贴片技术的先驱，该技术最初是为医疗创伤护理而设计的。儘管是先驱者，3M难以跟上时代的步伐，尤其是在Z世代等年轻消费族群。虽然其产品因其医疗功效而备受信赖，但3M未能掌握驱动当今护肤发展的大部分文化趋势。该品牌传统的形象和行销方式限制了其对年轻消费者的吸引力，这些年轻消费者寻求的是与自身价值观、美学和数位化互动偏好相契合的品牌。

主要成长驱动因素

痤疮贴市场最显着的成长动力源自于人们对这类产品的认知和使用方式的转变，而这一转变很大程度上得益于Starface和Squish Beauty等创新品牌的推动。传统上，痤疮贴被视为纯粹的医疗用品；也就是说，它们需要隐藏使用，藏匿起来，通常存放在药柜或浴室抽屉里。这种传统观念将痤疮贴片主要定位为一种用于私密治疗皮肤问题的「临床解决方案」。然而，Starface和Squish Beauty等品牌透过重新思考产品的设计和功能，彻底改变了这种认知，将痤疮贴从一种「隐藏的治疗方法」转变为一种大胆、有趣且富有表现力的时尚配件。

新机会的趋势

最新数据显示，男性消费者购买祛痘贴的数量显着增加，凸显了祛痘贴市场的新趋势，也带来了巨大的成长机会。男性使用者数量的成长主要源自于他们对祛痘贴的实用性和功能性认知，而非视为化妆品。对某些男性而言，与常被贴上“化妆品”或“虚荣”标籤的遮瑕膏和麵霜不同，祛痘贴被视为实用的“工具”、先进的“观点”，甚至可以与“OK绷”相提并论。这种认知的转变正在打破护肤传统的性别壁垒，促使更多男性将祛痘贴纳入日常整装仪容。

优化障碍

在痤疮治疗市场以及更广泛的生物医学市场中，由于微针贴片具有先进的药物传递能力和提升治疗效果的潜力，其需求正在不断增长。然而，微针贴片的生产製造面临许多障碍，主要体现在如何实现高产量比率和维持模具的耐久性。要生产出始终保持锋利、精准且坚固耐用的微针阵列，并在脱模过程中不发生断裂，需要高度精密的技术和对材料及生产过程的严格控制。

目录

第一章执行摘要：全球痤疮皮肤贴片市场

第二章：调查方法与研究框架

  • 研究目标
  • 产品概述
  • 市场区隔
  • 定性研究
    • 一手和二手资讯
  • 量化研究
    • 一手和二手讯息
  • 初步调查受访者组成：依地区划分
  • 本研究的先决条件
  • 市场规模估算
  • 数据检验

第三章：全球痤疮皮肤贴片市场概述

  • 产业价值链分析
    • 原物料供应商
    • 製造商
    • 销售代理
    • 最终用户
  • 产业展望
    • 世界各地的皮肤病
  • 消费行为分析
    • 人口统计分析
    • 消费者趋势和偏好
    • 影响购买决策的主要因素
    • 消费者产品采纳模式
    • 分析师的观察与建议
  • PESTLE分析
  • 波特五力分析
    • 供应商的议价能力
    • 买方的议价能力
    • 替代品的威胁
    • 新进入者的威胁
    • 竞争强度
  • 市场成长及前景
    • 市场获利估算与预测（2020-2035）
    • 市场规模估算与预测（2020-2035 年）
    • 价格趋势分析

第四章：全球痤疮皮肤贴片市场分析

  • 竞争格局概述
    • 市场集中度
    • 企业市场占有率分析（以金额为准，%），2025 年
    • 竞争对手分析与基准测试

第五章：全球痤疮皮肤贴片市场分析

  • 市场动态和趋势
    • 成长驱动因素
    • 抑制因子
    • 机会
    • 主要趋势
  • 市场规模及预测（2020-2035）
    • 依产品类型
    • 修补技术
    • 依成分类型
    • 按年龄组
    • 最终用户
    • 透过分销管道
    • 按地区

第六章：北美市场分析

第七章：欧洲市场分析

第八章：亚太市场分析

第九章：中东和非洲市场分析

第十章 南美洲市场分析

第十一章：公司简介

  • Peter Thomas Roth Labs LLC
  • Rael
  • ZitSticka
  • 3M Company
  • Starface
  • DermaAngel
  • Hero Cosmetics
  • Sephora USA, Inc.
  • Nurimedics Co., Ltd.
  • Peach &Lily
  • COSRX
  • Alba Botanica
  • Peace Out Skincare
  • 其他有潜力的企业

第十二章附录

简介目录
Product Code: AA02261714

The global anti-acne dermal patch market is experiencing rapid expansion, reflecting strong consumer demand and evolving skincare trends. Valued at approximately US$ 693.21 million in 2025, the market is projected to nearly double over the next decade, reaching an estimated valuation of US$ 1,277.11 million by 2035. This growth corresponds to a compound annual growth rate (CAGR) of 4.6% during the forecast period from 2026 to 2035. Several factors contribute to this robust market trajectory, including an increasing prevalence of acne worldwide, a growing preference for non-invasive treatment options, and the explosive expansion of e-commerce platforms that make these products more accessible to a broad audience.

One of the primary drivers behind this growth is the rising popularity of advanced patch technologies, particularly hydrocolloid and microneedle patches. Hydrocolloid patches remain favored for their affordability and proven effectiveness in treating acne, while microneedle patches attract consumers looking for innovative solutions that deliver active ingredients more efficiently. The combination of these technologies offers consumers a range of options tailored to different acne types and treatment needs, fueling market expansion.

Noteworthy Market Developments

The Western market leader in the anti-acne dermal patch segment has successfully established dominance in retail distribution by employing a strategy known as "SKU Proliferation." This approach involves offering a wide variety of product variants under a single brand umbrella to address every stage of acne and to effectively block competitors from gaining shelf space. By providing options such as Mighty Patch Original, Invisible, Surface, Micropoint, and Face, the brand ensures that consumers find a tailored solution for their specific needs, whether dealing with initial blemishes or more advanced breakouts.

In the realm of K-Beauty, COSRX stands out as a dominant force, particularly within the "cult favorite" segment and on e-commerce platforms like Amazon. COSRX has cultivated a loyal following by focusing on "Value Density," a concept that emphasizes delivering high-quality, effective products at affordable prices with concentrated active ingredients. This value proposition resonates strongly with consumers who seek reliable skincare solutions without a premium price tag. COSRX's reputation for innovation and efficacy is bolstered by its strategic positioning in the online marketplace, where customer reviews and brand visibility play crucial roles in driving sales.

On the other hand, 3M, the legacy player in this space, holds the distinction of having originally invented the hydrocolloid patch technology, initially designed for medical wound care. Despite being a pioneer, 3M has struggled to maintain cultural relevance, particularly with younger demographics such as Gen Z. While its products are trusted for medical efficacy, 3M has not successfully tapped into the cultural zeitgeist that drives much of today's skincare trends. The brand's more traditional image and marketing approach have limited its appeal among younger consumers who gravitate toward brands that align with their values, aesthetics, and digital engagement preferences.

Core Growth Drivers

The most significant growth driver in the anti-acne dermal patch market stems from a psychological shift in how these products are perceived and used, a transformation largely influenced by innovative brands such as Starface and Squish Beauty. Traditionally, acne patches were treated as purely medicinal items-something to be discreetly applied and hidden away, often stored in medicine cabinets or bathroom drawers. This conventional approach positioned acne patches as clinical solutions, associated primarily with treating imperfections discreetly and privately. However, brands like Starface and Squish Beauty have revolutionized this perception by reimagining the product's design and role, turning acne patches from invisible remedies into bold, fun, and expressive accessories.

Emerging Opportunity Trends

Recent data reveals a notable surge in male consumers purchasing acne patches, highlighting an emerging trend that presents significant growth opportunities within the anti-acne dermal patch market. This increase in male usage is largely driven by the perception of acne patches as practical and functional products rather than cosmetic ones. Unlike concealers or creams, which for some men carry a stigma associated with makeup or vanity, acne patches are viewed through a different lens-as utilitarian "tools," advanced "tech," or even comparable to "bandages." This shift in perception is helping to break down traditional gender barriers in skincare, opening the door for more men to adopt acne patches as part of their daily grooming routines.

Barriers to Optimization

The demand for microneedle patches in the anti-acne and broader biomedical markets is high due to their advanced delivery capabilities and potential for enhanced treatment efficacy. However, significant barriers to entry exist in their manufacturing, primarily related to achieving high yield and maintaining mold durability. Producing microneedle arrays that are consistently sharp, precise, and robust enough to withstand the de-molding process without breaking requires highly sophisticated technologies and meticulous control over materials and fabrication methods.

Detailed Market Segmentation

By Age Group, consumers aged 18 to 44 represent the dominant demographic in the global anti-acne dermal patch market, controlling the largest revenue share of approximately 54.69%. This age group encompasses a wide range of individuals, from late teens through young adulthood and into early middle age, who are particularly concerned with skin health and appearance. Acne is a prevalent issue among these consumers, often affecting their confidence and daily lives, which drives strong demand for effective treatment options like dermal patches. Their active engagement with skincare routines and openness to adopting innovative products contribute significantly to their market influence.

By Distribution, the distribution landscape of the global anti-acne dermal patch market has undergone a dramatic transformation, shifting away from traditional pharmacy aisles toward algorithm-driven social commerce platforms. This evolution reflects broader changes in consumer behavior, where digital channels and social media play an increasingly influential role in product discovery and purchasing decisions. Today, e-commerce leads the market, accounting for over 38.65% of the global share, highlighting the growing preference for online shopping among consumers seeking convenient access to skincare solutions.

By Product Type, the skincare industry has experienced a significant shift driven by the "medicalization" of skincare, where consumers increasingly favor active ingredient-based treatments over passive or purely cosmetic options. This trend has had a profound impact on the global anti-acne dermal patch market, influencing purchasing behavior and product development. As a result, chemical-based patches have emerged as the dominant product type, commanding a substantial 69.01% share of the market. This dominance reflects a growing consumer preference for more potent, targeted solutions that promise visible improvements in a shorter time frame.

  • In terms of Patch Technology, Hydrocolloid patches hold the largest market share, accounting for approximately 55.84%, making them the undisputed leader in the category. This dominance can be attributed to several factors, including their affordability, proven effectiveness, and widespread consumer acceptance. Hydrocolloid patches have long been trusted for their ability to absorb excess fluids from acne lesions and protect the skin, making them a staple in many skincare routines worldwide.

Segment Breakdown

By Product Type

  • Chemical-Based Patches
  • Herbal-Based Patches

By Patch Technology

  • Hydrocolloid
  • Microneedle
  • Hydrogel
  • Silicone

By Ingredient Type

  • Salicylic Acid
  • Tea-Tree Oil
  • Niacinamide
  • Hyaluronic Acid
  • Others

By Age Group

  • 10 to 17 years
  • 18 to 44 years
  • 45 to 64 years
  • 65+ years

By End User

  • Individual Consumers
  • Dermatology Clinics
  • Medical Spas
  • Retail Pharmacies

By Distribution Channel

  • Retail Stores
  • Pharmacies & Drug Stores
  • E-commerce Platforms
  • Specialty Beauty Retailers
  • Supermarkets / Convenience Stores

By Region

  • North America
  • The U.S.
  • Canada
  • Mexico
  • Europe
  • Western Europe
  • The UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Western Europe
  • Eastern Europe
  • Poland
  • Russia
  • Rest of Eastern Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa (MEA)
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of MEA
  • South America
  • Argentina
  • Brazil
  • Rest of South America

Geography Breakdown

  • The Asia Pacific region currently dominates the global anti-acne dermal patch market, holding a commanding share of over 50.53%. This dominance reflects the region's strong manufacturing capabilities, innovation leadership, and large consumer base. South Korea, in particular, is recognized as a powerhouse in this market, much like Taiwan's reputation in the semiconductor industry. It is estimated that approximately 75-80% of global original equipment manufacturer (OEM) innovations in anti-acne dermal patches originate from this region.
  • China plays a dual role in the Asia Pacific anti-acne dermal patch market. On one hand, it represents a massive consumption market due to its large population and rising beauty consciousness, driving significant demand for skincare products, including anti-acne patches. On the other hand, China poses a supply chain challenge for the region. Chinese manufacturers are rapidly improving the quality of their hydrocolloid materials, which are essential for effective dermal patches, and are aggressively competing on price.
  • The broader Asia Pacific region benefits from a combination of factors that reinforce its market dominance. The availability of skilled labor, relatively lower production costs compared to Western countries, and large domestic markets enable companies to optimize resources and scale efficiently. Countries like South Korea and Taiwan continue to refine their manufacturing processes and maintain a technological edge, while China, India, and Southeast Asian nations expand their roles by leveraging cost advantages and growing expertise.

Leading Market Participants

  • Peter Thomas Roth Labs LLC
  • Rael
  • ZitSticka
  • 3M Company
  • Starface
  • DermaAngel
  • Hero Cosmetics
  • Sephora USA, Inc.
  • Nurimedics Co., Ltd.
  • Peach & Lily
  • COSRX
  • Alba Botanica
  • Peace Out Skincare
  • Other Prominent Players

Table of Content

Chapter 1. Executive Summary: Global Anti-acne Dermal Patch Market

Chapter 2. Research Methodology & Research Framework

  • 2.1. Research Objective
  • 2.2. Product Overview
  • 2.3. Market Segmentation
  • 2.4. Qualitative Research
    • 2.4.1. Primary & Secondary Sources
  • 2.5. Quantitative Research
    • 2.5.1. Primary & Secondary Sources
  • 2.6. Breakdown of Primary Research Respondents, By Region
  • 2.7. Assumption for Study
  • 2.8. Market Size Estimation
  • 2.9. Data Triangulation

Chapter 3. Global Anti-acne Dermal Patch Market Overview

  • 3.1. Industry Value Chain Analysis
    • 3.1.1. Raw Material Suppliers
    • 3.1.2. Manufacturers
    • 3.1.3. Distributors
    • 3.1.4. End Users
  • 3.2. Industry Outlook
    • 3.2.1. Skin Diseases in the World
  • 3.3. Consumer Behavior Analysis
    • 3.3.1. Demographic Analysis
    • 3.3.2. Consumer Trends and Preferences
    • 3.3.3. Key Factors Influencing Purchase Decisions
    • 3.3.4. Consumer Product Adoption Patterns
    • 3.3.5. Analyst Observations and Recommendations
  • 3.4. PESTLE Analysis
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of Substitutes
    • 3.5.4. Threat of New Entrants
    • 3.5.5. Degree of Competition
  • 3.6. Market Growth and Outlook
    • 3.6.1. Market Revenue Estimates and Forecast (US$ Mn), 2020-2035
    • 3.6.2. Market Volume Estimates and Forecast (Units), 2020-2035
    • 3.6.3. Price Trend Analysis

Chapter 4. Global Anti-acne Dermal Patch Market Analysis

  • 4.1. Competition Dashboard
    • 4.1.1. Market Concentration Rate
    • 4.1.2. Company Market Share Analysis (Value %), 2025
    • 4.1.3. Competitor Mapping & Benchmarking

Chapter 5. Global Anti-acne Dermal Patch Market Analysis

  • 5.1. Market Dynamics and Trends
    • 5.1.1. Growth Drivers
    • 5.1.2. Restraints
    • 5.1.3. Opportunity
    • 5.1.4. Key Trends
  • 5.2. Market Size and Forecast, 2020-2035 (US$ Mn & Units)
    • 5.2.1. By Product Type
      • 5.2.1.1. Key Insights
        • 5.2.1.1.1. Chemical-Based Patches
        • 5.2.1.1.2. Herbal-Based Patches
    • 5.2.2. By Patch Technology
      • 5.2.2.1. Key Insights
        • 5.2.2.1.1. Hydrocolloid
        • 5.2.2.1.2. Microneedle
        • 5.2.2.1.3. Hydrogel
        • 5.2.2.1.4. Silicone
    • 5.2.3. By Ingredient Type
      • 5.2.3.1. Key Insights
        • 5.2.3.1.1. Salicyclic Acid
        • 5.2.3.1.2. Tea-Tree Oil
        • 5.2.3.1.3. Niacinamide
        • 5.2.3.1.4. Hyaluronic Acid
        • 5.2.3.1.5. Others
    • 5.2.4. By Age Group
      • 5.2.4.1. Key Insights
        • 5.2.4.1.1. 10 to 17 years
        • 5.2.4.1.2. 18 to 44 years
        • 5.2.4.1.3. 45 to 64 years
        • 5.2.4.1.4. 65+ years
    • 5.2.5. By End User
      • 5.2.5.1. Key Insights
        • 5.2.5.1.1. Individual Consumers
        • 5.2.5.1.2. Dermatology Clinics
        • 5.2.5.1.3. Medical Spas
        • 5.2.5.1.4. Retail Pharmacies
    • 5.2.6. By Distribution Channel
      • 5.2.6.1. Key Insights
        • 5.2.6.1.1. Retail Stores
        • 5.2.6.1.2. Pharmacies & Drug Stores
        • 5.2.6.1.3. E-commerce Platforms
        • 5.2.6.1.4. Specialty Beauty Retailers
        • 5.2.6.1.5. Supermarkets / Convenience Stores
    • 5.2.7. By Region
      • 5.2.7.1. Key Insights
        • 5.2.7.1.1. North America
          • 5.2.7.1.1.1. The U.S.
          • 5.2.7.1.1.2. Canada
          • 5.2.7.1.1.3. Mexico
        • 5.2.7.1.2. Europe
          • 5.2.7.1.2.1. Western Europe
            • 5.2.7.1.2.1.1. The UK
            • 5.2.7.1.2.1.2. Germany
            • 5.2.7.1.2.1.3. France
            • 5.2.7.1.2.1.4. Italy
            • 5.2.7.1.2.1.5. Spain
            • 5.2.7.1.2.1.6. Rest of Western Europe
          • 5.2.7.1.2.2. Eastern Europe
            • 5.2.7.1.2.2.1. Poland
            • 5.2.7.1.2.2.2. Russia
            • 5.2.7.1.2.2.3. Rest of Eastern Europe
        • 5.2.7.1.3. Asia Pacific
          • 5.2.7.1.3.1. China
          • 5.2.7.1.3.2. India
          • 5.2.7.1.3.3. Japan
          • 5.2.7.1.3.4. South Korea
          • 5.2.7.1.3.5. Australia & New Zealand
          • 5.2.7.1.3.6. ASEAN
            • 5.2.7.1.3.6.1. Indonesia
            • 5.2.7.1.3.6.2. Malaysia
            • 5.2.7.1.3.6.3. Thailand
            • 5.2.7.1.3.6.4. Singapore
            • 5.2.7.1.3.6.5. Rest of ASEAN
          • 5.2.7.1.3.7. Rest of Asia Pacific
        • 5.2.7.1.4. Middle East & Africa
          • 5.2.7.1.4.1. UAE
          • 5.2.7.1.4.2. Saudi Arabia
          • 5.2.7.1.4.3. South Africa
          • 5.2.7.1.4.4. Rest of MEA
        • 5.2.7.1.5. South America
          • 5.2.7.1.5.1. Argentina
          • 5.2.7.1.5.2. Brazil
          • 5.2.7.1.5.3. Rest of South America

Chapter 6. North America Market Analysis

  • 6.1. Market Dynamics and Trends
    • 6.1.1. Growth Drivers
    • 6.1.2. Restraints
    • 6.1.3. Opportunity
    • 6.1.4. Key Trends
  • 6.2. Market Size and Forecast, 2020-2035 (US$ Mn & Units)
    • 6.2.1. Key Insights
      • 6.2.1.1. By Product Type
      • 6.2.1.2. By Patch Technology
      • 6.2.1.3. By Ingredient Type
      • 6.2.1.4. By Age Group
      • 6.2.1.5. By End User
      • 6.2.1.6. By Distribution Channel
      • 6.2.1.7. By Country

Chapter 7. Europe Market Analysis

  • 7.1. Market Dynamics and Trends
    • 7.1.1. Growth Drivers
    • 7.1.2. Restraints
    • 7.1.3. Opportunity
    • 7.1.4. Key Trends
  • 7.2. Market Size and Forecast, 2020-2035 (US$ Mn & Units)
    • 7.2.1. Key Insights
      • 7.2.1.1. By Product Type
      • 7.2.1.2. By Patch Technology
      • 7.2.1.3. By Ingredient Type
      • 7.2.1.4. By Age Group
      • 7.2.1.5. By End User
      • 7.2.1.6. By Distribution Channel
      • 7.2.1.7. By Country

Chapter 8. Asia Pacific Market Analysis

  • 8.1. Market Dynamics and Trends
    • 8.1.1. Growth Drivers
    • 8.1.2. Restraints
    • 8.1.3. Opportunity
    • 8.1.4. Key Trends
  • 8.2. Market Size and Forecast, 2020-2035 (US$ Mn & Units)
    • 8.2.1. Key Insights
      • 8.2.1.1. By Product Type
      • 8.2.1.2. By Patch Technology
      • 8.2.1.3. By Ingredient Type
      • 8.2.1.4. By Age Group
      • 8.2.1.5. By End User
      • 8.2.1.6. By Distribution Channel
      • 8.2.1.7. By Country

Chapter 9. Middle East & Africa Market Analysis

  • 9.1. Market Dynamics and Trends
    • 9.1.1. Growth Drivers
    • 9.1.2. Restraints
    • 9.1.3. Opportunity
    • 9.1.4. Key Trends
  • 9.2. Market Size and Forecast, 2020-2035 (US$ Mn & Units)
    • 9.2.1. Key Insights
      • 9.2.1.1. By Product Type
      • 9.2.1.2. By Patch Technology
      • 9.2.1.3. By Ingredient Type
      • 9.2.1.4. By Age Group
      • 9.2.1.5. By End User
      • 9.2.1.6. By Distribution Channel
      • 9.2.1.7. By Country

Chapter 10. South America Market Analysis

  • 10.1. Market Dynamics and Trends
    • 10.1.1. Growth Drivers
    • 10.1.2. Restraints
    • 10.1.3. Opportunity
    • 10.1.4. Key Trends
  • 10.2. Market Size and Forecast, 2020-2035 (US$ Mn & Units)
    • 10.2.1. Key Insights
      • 10.2.1.1. By Product Type
      • 10.2.1.2. By Patch Technology
      • 10.2.1.3. By Ingredient Type
      • 10.2.1.4. By Age Group
      • 10.2.1.5. By End User
      • 10.2.1.6. By Distribution Channel
      • 10.2.1.7. By Country

Chapter 11.Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

  • 11.1. Peter Thomas Roth Labs LLC
  • 11.2. Rael
  • 11.3. ZitSticka
  • 11.4. 3M Company
  • 11.5. Starface
  • 11.6. DermaAngel
  • 11.7. Hero Cosmetics
  • 11.8. Sephora USA, Inc.
  • 11.9. Nurimedics Co., Ltd.
  • 11.10. Peach & Lily
  • 11.11. COSRX
  • 11.12. Alba Botanica
  • 11.13. Peace Out Skincare
  • 11.14. Other Prominent Players

Chapter 12. Annexure

  • 12.1. List of Secondary Sources
  • 12.2. Key Country Markets- Macro Economic Outlook/Indicators